Who
Emily Gottschalk
Director
Company insider
Files Form 4 as: Director, Anixa Biosciences.
In numbers
- Trades disclosed
- 12
- Buys
- 3
- Sells
- 0
- Bought
- $200K
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 1
- First trade
- 23 Oct 2019
- Last trade
- 5 Jan 2026
- Last filed
- 6 Jan 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 5 Jan 2026filed 6 Jan 2026 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 5 Jan 2026filed 6 Jan 2026 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 2 Jan 2025filed 3 Jan 2025 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 12 Jan 2024filed 16 Jan 2024 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 3 Jan 2023filed 4 Jan 2023 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —25,000 at $0.00 | filing |
| 10 Mar 2022filed 11 Mar 2022 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
| 15 Jul 2021filed 16 Jul 2021 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $79K20,065 at $3.96 | filing |
| 1 Jun 2021filed 2 Jun 2021 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 23 Apr 2021filed 23 Apr 2021 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $45K10,000 at $4.49 | filing |
| 25 Mar 2021filed 26 Mar 2021 | ANIX Anixa BiosciencesBiotechnology | SEC FORM 4 Bought | $76K15,600 at $4.88 | filing |
| 13 Aug 2020filed 17 Aug 2020 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —30,000 at $0.00 | filing |
| 23 Oct 2019filed 24 Oct 2019 | ANIX Anixa Biosciencesoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,000 at $0.00 | filing |
News
Immatics (NASDAQ:IMTX) & Anixa Biosciences (NASDAQ:ANIX) Financial ComparisonANIX · dailypolitical.com · 16 Oct 2026Join Anixa Biosciences' Live Investor Webinar: Advancing Innovative CAR-T Therapy for Ovarian Cancer and a First-in-Class Breast Cancer VaccineANIX · hawaiitelegraph.com · 13 Oct 2026
0 headlines in the last 90 days name Emily Gottschalk; 2 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.